Clinical Trial Update: Optimised Decrement Evoked Potential (DeEP) Mapping to Guide Ventricular Tachycardia (VT) Ablation in Patients With Structural Heart Disease VT [NA]

View source ↗

Summary

Ongoing clinical trial evaluating Optimised Decrement Evoked Potential (DeEP) mapping to guide ventricular tachycardia ablation in patients with structural hear…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Structural Heart Disease
• Ventricular Tachycardia

Snippet

Sponsor: University Hospitals Coventry and Warwickshire NHS Trust | Conditions: Structural Heart Disease | NA | Status: RECRUITING